238 related articles for article (PubMed ID: 35146583)
1. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
Dézsi L; Mészáros T; Kozma G; H-Velkei M; Oláh CZ; Szabó M; Patkó Z; Fülöp T; Hennies M; Szebeni M; Barta BA; Merkely B; Radovits T; Szebeni J
Geroscience; 2022 Apr; 44(2):597-618. PubMed ID: 35146583
[TBL] [Abstract][Full Text] [Related]
2. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.
Barta BA; Radovits T; Dobos AB; Tibor Kozma G; Mészáros T; Berényi P; Facskó R; Fülöp T; Merkely B; Szebeni J
Vaccine X; 2024 Aug; 19():100497. PubMed ID: 38933697
[TBL] [Abstract][Full Text] [Related]
3. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
Kozma GT; Mészáros T; Berényi P; Facskó R; Patkó Z; Oláh CZ; Nagy A; Fülöp TG; Glatter KA; Radovits T; Merkely B; Szebeni J
Vaccine; 2023 Jul; 41(31):4561-4570. PubMed ID: 37330369
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
[TBL] [Abstract][Full Text] [Related]
5. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
[TBL] [Abstract][Full Text] [Related]
6. Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine).
Bavli Y; Chen BM; Gross G; Hershko A; Turjeman K; Roffler S; Barenholz Y
J Control Release; 2023 Feb; 354():316-322. PubMed ID: 36549393
[TBL] [Abstract][Full Text] [Related]
7. Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.
Mészáros T; Kozma GT; Shimizu T; Miyahara K; Turjeman K; Ishida T; Barenholz Y; Urbanics R; Szebeni J
Int J Nanomedicine; 2018; 13():6345-6357. PubMed ID: 30349254
[TBL] [Abstract][Full Text] [Related]
8. Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice.
Őrfi E; Mészáros T; Hennies M; Fülöp T; Dézsi L; Nardocci A; Rosivall L; Hamar P; Neun BW; Dobrovolskaia MA; Szebeni J; Szénási G
Int J Nanomedicine; 2019; 14():1563-1573. PubMed ID: 30880965
[TBL] [Abstract][Full Text] [Related]
9. Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine.
Münter R; Sørensen E; Hasselbalch RB; Christensen E; Nielsen SD; Garred P; Ostrowski SR; Bundgaard H; Iversen KK; Andresen TL; Larsen JB
Mol Pharm; 2023 Jul; 20(7):3356-3366. PubMed ID: 36952227
[TBL] [Abstract][Full Text] [Related]
10. A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood.
Pethő Á; Piecha D; Mészáros T; Urbanics R; Moore C; Canaud B; Rosivall L; Mollnes TE; Steppan S; Szénási G; Szebeni J; Dézsi L
Ren Fail; 2021 Dec; 43(1):1609-1620. PubMed ID: 34882053
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.
Szebeni J; Fontana JL; Wassef NM; Mongan PD; Morse DS; Dobbins DE; Stahl GL; Bünger R; Alving CR
Circulation; 1999 May; 99(17):2302-9. PubMed ID: 10226097
[TBL] [Abstract][Full Text] [Related]
12. Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose.
Apostolidou E; Dimitriou K; Papadopoulou A; Mikos N; Kompoti E
Cureus; 2023 Mar; 15(3):e36064. PubMed ID: 37056532
[TBL] [Abstract][Full Text] [Related]
13. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
[TBL] [Abstract][Full Text] [Related]
14. Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model.
Jackman JA; Mészáros T; Fülöp T; Urbanics R; Szebeni J; Cho NJ
Nanomedicine; 2016 May; 12(4):933-943. PubMed ID: 26767512
[TBL] [Abstract][Full Text] [Related]
15. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
[TBL] [Abstract][Full Text] [Related]
16. Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.
Klimek L; Novak N; Cabanillas B; Jutel M; Bousquet J; Akdis CA
Allergy; 2021 Nov; 76(11):3307-3313. PubMed ID: 33657648
[TBL] [Abstract][Full Text] [Related]
17. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
[TBL] [Abstract][Full Text] [Related]
18. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
Szebeni J; Alving CR; Rosivall L; Bünger R; Baranyi L; Bedöcs P; Tóth M; Barenholz Y
J Liposome Res; 2007; 17(2):107-17. PubMed ID: 17613700
[TBL] [Abstract][Full Text] [Related]
19. Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes.
Szebeni J; Kiss B; Bozó T; Turjeman K; Levi-Kalisman Y; Barenholz Y; Kellermayer M
ACS Nano; 2023 Jul; 17(14):13147-13157. PubMed ID: 37417667
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
Wang M; Wen W; Zhou M; Wang C; Feng ZH
Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
